Lv2
158 积分 2024-01-02 加入
Biliary tract cancer
2个月前
已完结
Response to chemotherapy and prognosis in metastatic colorectal cancer with DNA deficient mismatch repair
3个月前
已完结
First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study
3个月前
已完结
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
3个月前
已完结
Industry Perspective on First-in-Human and Clinical Pharmacology Strategies to Support Clinical Development of T-Cell Engaging Bispecific Antibodies for Cancer Therapy
8个月前
已完结
The power of sample size calculations
9个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
9个月前
已完结
皖公网安备34019202002308
